MedPath

The feasibility of endoscopic functional luminal imaging probe in reflux disease

Completed
Conditions
Diseases of the digestive system
Registration Number
KCT0004156
Lead Sponsor
Bundang CHA General Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
900
Inclusion Criteria

All patients who were between 15 and 79 years old, with reflux symptoms, and scheduled to undergo a screening gastroscopy and EndoFLIP® were included in this study. According to the results, patients with erosive esophagitis, determined by gastroscopy, were referred to the ERD group, while patients with no erosive esophagitis, but with abnormalities observed over 24-hour pH monitoring were classified as the NERD group.12 Healthy controls were on no regular medications and had no symptoms of reflux disease, but did have nonspecific symptoms, such as dyspepsia or abdominal discomfort.

Exclusion Criteria

(1) unable to receive a gastroscopy or EndoFLIP®; (2) unable to provide informed consent; (3) hemodynamic instability (systolic blood pressure [SBP] < 90 mmHg), or if the peripheral oxygen saturation (SpO2) was 90% in room air, or < 95% on 2 L/min of oxygen at baseline before the procedure; (4) psychological problems; (5) acute severe infection; (6) evidence of esophageal
motility disorder on esophageal manometry.

Study & Design

Study Type
Observational Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
cross sectional area, distensiblity index
Secondary Outcome Measures
NameTimeMethod
Residual LES pressure, 24-hr ambulatory pH monitoring
© Copyright 2025. All Rights Reserved by MedPath